Mediwelcome Healthcare Management & Technology Inc. released its Monthly Return for the period ended 31 July 2026, confirming a stable share-capital profile and ongoing adherence to Hong Kong Stock Exchange public-float requirements.
Authorised and Registered Capital • Authorised share capital remained unchanged at 38.00 billion ordinary shares with a par value of HKD 0.00001, equivalent to HKD 0.38 million.
Issued Share Capital and Treasury Position • Issued ordinary shares stood firm at 280.00 million, with no treasury shares held or cancelled during the month. • No new shares were issued, repurchased, or cancelled, leaving total issued share capital unchanged.
Public-Float Status • The company affirmed compliance with the Main Board’s minimum 25% public-float threshold as at 31 July 2026.
Equity Incentives • Under the Share Option Scheme adopted on 21 December 2020, 20.00 million share options were outstanding at month-end. • No share options were exercised, granted, lapsed, or cancelled during July, and no shares were issued or transferred pursuant to the scheme.
Other Equity Instruments • The issuer reported no outstanding or newly issued warrants, convertible securities, Hong Kong depositary receipts, or other equity-linked instruments for the month.
Governance Confirmation • The Monthly Return was submitted by Company Secretary Chen Ming Mei Josephine on 03 August 2026, with all disclosures made in accordance with Hong Kong Listing Rules.
The July 2026 filing underscores Mediwelcome’s unchanged capital structure and continued regulatory compliance, providing shareholders with clarity on the company’s equity position.
Comments